Adjuvant effects of saponins on animal immune responses

Allison, A., 1979. Mode of action of immunological adjuvants. J. Reticuloendothel. Soc., 26(Suppl.):619–630.

Allison, A.C., Byars, N.E., 1991. Immunological adjuvants: desirable properties and side-effects. Mol. Immunol., 28(3):279–284. [doi: 10.1016/0161-5890(91)90074-T]

Bangham, A.D., Horne, R.W., Glauert, A.M., Dingle, J.T., Lucy, J.A., 1962. Action of saponins on biological membranes. Nature, 196(4858):952–955. [doi: 10.1038/196952a0]

Barr, I.G., Sjolander, A., Cox, J.C., 1998. ISCOMs and other saponin based adjuvants (review). Adv. Drug Deliv. Rev., 32(3):247–271. [doi: 10.1016/S0169-409X(98)00013-1]

Bomford, R., 1998. Will Adjuvants be Needed for Vaccines of the Future? In: Brown, F., Haaheim, L.R. (Eds.), Modulation of the Immune Response to Vaccine Antigens, Vol. 92. Development in Biological Standardization, Basel, Karger, p.13–17.

Bomford, R., Stapleton, M., Winsor, S., Beesley, J.E., Jessup, E.A., Price, K.R., Fenwick, G.R., 1992. Adjuvanticity and ISCOM formation by structurally diverse saponins. Vaccine, 10(9):572–577. [doi: 10.1016/0264-410X(92)90435-M]

Bowersock, T.L., Martin, S., 1999. Vaccine delivery to animals. Adv. Drug Deliv. Rev., 38(2):167–194. [doi: 10.1016/S0169-409X(99)00015-0]

Byars, N.E., Allison, A.C., 1990. Immunologic Adjuvants: General Properties, Advantages, and Limitations. In: Zola, H. (Ed.), Laboratory Methods in Immunology. Boca Raton, CRC Press, p.39–51.

Chang, H.M., But, P.P., 1986. Pharmacology and Applications of Chinese Materia Medica, Vol. 1. Singapore, World Scientific, p.1041.

Chavali, S.R., Campbell, J.B., 1987a. Immunomodulatory effects of orally-administered saponins and nonspecific resistance against rabies infection. Int. Arch. Allergy Appl. Immunol., 84(2):129–134.

Chavali, S.R., Campbell, J.B., 1987b. Adjuvant effects of orally administered saponins on humoral and cellular immune responses in mice. Immunobiology, 174(3):347–359.

Chavali, S.R., Francis, T., Campbell, J.B., 1987. An in-vitro study of immunomodulatory effects of some saponins. Int. J. Immunopharmacol., 9(6):675–684. [doi: 10.1016/0192-0561(87)90038-5]

Chen, X.M., Xu, Y.J., Tian, G.Y., 2005. Physical-chemical properties and structure elucidation of abPS isolated from the root of Achyranthes bidentata. Acta Pharm. Sin., 40(1):32–35.

Chu, D.T., Lin, J.R., Wong, W., 1994. The in vitro potentiation of LAK cell cytotoxicity in cancer and AIDS patients induced by F3-a fractionated extract of Astragalus membranaceus. Chin. J. Oncol., 16(3):167–171.

Cohen, J., Marshall, E., 2001. Bioterrorism. Vaccines for biodefense: a system in distress. Science, 294(5542):498–501. [doi: 10.1126/science.294.5542.498]

Cossarini-Dunier, M., 1985. Effect of different adjuvants on the humoral immune response of rainbow trout. Dev. Comp. Immunol., 9(1):141–146. [doi: 10.1016/0145-305X(85)90067-9]

Coulter, A., Wong, T.Y., Drane, D., Bates, J., Macfarlan, R., Cox, J., 1998. Studies on experimental adjuvanted influenza vaccines: comparison of immune stimulating complexes Iscoms (T.M.) and oil-in-water vaccines. Vaccine, 16(11/12):1243–1253. [doi: 10.1016/S0264-410X(98)80125-4]

Cox, J.C., Coulter, A.R., 1992. Advances in Adjuvant Technology and Application. In: Yong, W.K. (Ed.), Animal Parasite Control Utilizing Bio-technology. CRC Press, Boca Raton, p.49–112.

Cox, J.C., Coulter, A.R., 1997. Adjuvants—a classification and review of their modes of action. Vaccine, 15(3):248–256. [doi: 10.1016/S0264-410X(96)00183-1]

Crouch, C.F., Daly, J., Henley, W., Hannant, D., Wilkins, J., Francis, M.J., 2005. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses. Vet. Immunol. Immunopathol., 108(3–4):345–355. [doi: 10.1016/j.vetimm.2005.06.009]

Curtiss, R., 2002. Bacterial infectious disease control by vaccine development. J. Clin. Invest., 110(8):1061–1066. [doi: 10.1172/JCI200216941]

Dalsgaard, K., 1987. Adjuvants. Vet. Immunol. Immunopathol, 17(1–4):145–152. [doi: 10.1016/0165-2427(87)90135-8]

de Oliveira, C.A.C., Perez, A.C., Merino, G., Prieto, J.G., Alvarez, A.I., 2001. Protective effects of Panax ginseng on muscle injury and inflammation after eccentric exercise. Comp. Biochem. Physiol., 130(3):369–377.

Delmas, F., Di Giorgio, C., Elias, R., Gasquet, M., Azas, N., Mshvildadze, V., Dekanosidze, G., Kemertelidze, E., Timon-David, P., 2000. Antileishmanial activity of three saponins isolated from ivy, alpha-hederin, beta-hederin and hederacolchiside A(1), as compared with their action on mammalian cells cultured in vitro. Planta Medica, 66(4):343–347. [doi: 10.1055/s-2000-8541]

Edelman, R., 1997. Adjuvants for the Future. In: Levine, M.M., Woodrow, G.C., Kaper, J.B., Cobon, G.S. (Eds.), New Generation Vaccines. Marcel Deker Inc., New York, p.173–192.

Evans, T.G., McElrath, M.J., Matthews, T., Montefiori, D., Weinhold, K., Wolff, M., Keefer, M.C., Kallas, E.G., Corey, L., Gorse, G.J., et al., 2001. QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans. Vaccine, 19(15–16):2080–2091. [doi: 10.1016/S0264-410X(00)00415-1]

Fearon, D.T., 1997. Seeking wisdom in innate immunity. Nature, 388(6640):323–324. [doi: 10.1038/40967]

Fenwick, G.R., Price, K.R., Tsukamoto, C., Okubo, K., 1991. Saponins. In: Mello, F.J.P.D., Duffus, C.M., Duffus, J.H. (Eds.), Saponins in Toxic Substances in Crop Plants. The Royal Society of Chemistry, Cambridge, p.285–327.

Francis, G., Kerem, Z., Makkar, H.P.S., Becker, K., 2002. The biological action of saponins in animal system: a review. Br. J. Nutr., 88(6):587–605. [doi: 10.1079/BJN2002725]

Gong, X.M., Wu, Y.Z., 1996. Research actuality and tendency of immune adjuvant. Chin. J. Vet. Drug, 1:41–44.

Grayson, T.H., Williams, R.J., Wrathmell, A.B., Munn, C.B., Harris, J.E., 1987. Effects of immunopotentiating agents on the immune response of rainbow trout, Salmo gairdneri Richardson, to ERM vaccine. J. Fish Biol., 31(sa):195–202. [doi: 10.1111/j.1095-8649.1987.tb05313x]

Gupta, R.K., 1998. Aluminum compounds as a vaccine adjuvants. Adv. Drug Deliv. Rev., 32(3):155–172. [doi: 10.1016/S0169-409X(98)00008-8]

Gupta, R.K., Relyveld, E.H., Lindblad, E.B., Bizzini, B., Ben-Efraim, S., Gupta, C.K., 1993. Adjuvants—a balance between toxicity and adjuvanticity. Vaccine, 11(3):293–306. [doi: 10.1016/0264-410X(93)90190-9]

Gupta, R.K., Rost, B.E., Relyveld, E., Siber, G.R., 1995. Adjuvant properties of aluminum and calcium compounds. Pharm. Biotechnol., 6:229–248.

Haridas, V., Arntzen, C.J., Gutterman, J.U., 2001. Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), inhibit activation of nuclear factor-kappa B by inhibiting both its nuclear localization and ability to bind DNA. Proc. Natl. Acad. Sci. USA, 98(20):11557–11562. [doi: 10.1073/pnas.191363498]

Haridas, V., Hanausek, M., Nishimura, G., Soehnge, H., Gaikwad, A., Narog, M., Spears, E., Zoltaszek, R., Walaszek, Z., Gutterman, J.U., 2004. Triterpenoid electrophiles (avicins) activate the innate stress response by redox regulation of a gene battery. J. Clin. Invest., 113(1):65–73. [doi: 10.1172/JCI200418699]

Helgeby, A., Robson, N.C., Donachie, A.M., Beackock-Sharp, H., Lovgren, K., Schon, K., Mowat, A., Lycke, N.Y., 2006. The combined CTA1-DD/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells. J. Immunol., 176(6):3697–3706.

Hu, S., Concha, C., Cooray, R., Holmberg, O., 1995. Ginseng enhanced oxidative and phagocytic activities of polymorphonulear leukocytes from bovine peripheral blood and stripping milk. Vet. Res., 26(3):155–161.

Hu, S., Concha, C., Johannisson, A., Meglia, G., Waller, K.P., 2001. Effect of subcutaneous injection of ginseng on cows with sub-clinical Staphylococcus aureus mastitis. J. Vet. Med. Sci. B, 48(7):519–528. [doi: 10.1046/j.1439-0450.2001.00470.x]

Hunter, R.L., Olsen, M.R., Bennett, B., 1995. Copolymer Adjuvants and TiterMax®. In: Stewart-Tull, D.E.S. (Ed.), The Theory and Practical Application of Adjuvants. Wiley, New York, p.51–94.

Jacobsen, N.E., Fairbrother, W.J., Kensil, C.R., Lim, A., Wheeler, D.A., Powell, M.F., 1996. Structure of the saponin adjuvant QS-21 and its base-catalyzed isomerization product by 1H and natural abundance 13C NMR spectroscopy. Carbohydr. Res., 280(1):1–14. [doi: 10.1016/0008-6215(95)00278-2]

Jennings, R., Simms, J.R., Heath, A.W., 1998. Adjuvants and Delivery Systems for Viral Vaccines-Mechanisms and Potential. In: Brown, F., Haaheim, L.R. (Eds.), Modulation of the Immune Response to Vaccine Antigens, Vol. 92. Development in Biological Standardization, Basel, Karger, p.19–28.

Jie, Y.H., Cammisuli, S., Baggliolini, M., 1984. Immunomodulatory effects of Panax ginseng CA Meyer in the mouse. Agents Actions, 15(3–4):386–391. [doi: 10.1007/BF01972376]

Jin, C.D., 1996. Advances on analytical methods of the chemical constituents of ginseng. Chin. Herb. Med., 27:631–633.

Kaeberle, M.L., 1986. Functions of Current Adjuvants in Induction of Immune Response. In: Nervig, R.M., Gough, P.M., Kaeberle, M.L., Whetstone, C.A. (Eds.), Advances in Carriers and Adjuvants for Veterinary Biologics, Iowa State University Press, Ames, IA, p.11–24.

Kensil, C.R., 1996. Saponins as vaccine adjuvants. Crit. Rev. Ther. Drug Carrier Syst., 13(1–2):1–55.

Kensil, C.R., Patel, U., Lennick, M., Marciani, D., 1991. Separation and characterization of saponins with adjuvant activity from Quillaja-saponaria molina cortex. J. Immunol., 146(2):431–437.

Kensil, C.R., Wu, J.Y., Soltysik, S., 1995. Structural and Immunological Characterization of the Vaccine Adjuvant QS-21. In: Powell, M.F., Newman, M.J. (Eds.), Vaccine Design. The Subunit and Adjuvant Approach. Plenum Press, New York, p.525–541.

Khalil, A.H., El-Adawy, T.A., 1994. Isolation, identification and toxicity of saponin from different legumes. Food Chem., 50(2):197–201. [doi: 10.1016/0308-8146(94)90120-1]

Kong, X., Hu, Y., Rui, R., Wang, D., Li, X., 2004. Effects of Chinese herbal medicinal ingredients on peripheral lymphocyte proliferation and serum antibody titer after vaccination in chicken. Int. Immunopharmacol., 4(7):975–982. [doi: 10.1016/j.intimp.2004.03.008]

Lacaille-Dubois, M.A., Hanquet, B., Cui, Z.H., Lou, Z.C., Wagner, H., 1999. A new biologically active acylated triterpene saponin from Silene fortunei. J. Nat. Prod., 62(1):133–136. [doi: 10.1021/np980172y]

Li, C.C., Hu, X.G., Zhang, W.X., Xie, L.W., Zhang, H.Y., Dong, L., Cai, X.H., Wu, R.X., Zhang, Z.X., He, Q.S., 2003. Eosinophils apoptosis, fas mRNA and bcl-2 mRNA expressions in asthma model of young rat and effects of Achyranthes bidentata polysaccharides. Chin. J. Pediatr., 41(9):657–660.

Li, J.X., Hareyama, T., Tezuka, Y., Zhang, Y., Miyahara, T., Kadota, S., 2005. Five new oleanolic acid glycosides from Achyranthes bidentata with inhibitory activity on osteoclast formation. Planta Med., 71(7):673–679. [doi: 10.1055/s-2005-871275]

Liu, M., Zhang, J., 1995. Stimulatory effect of ginsenosides Rg1 aged rats. Yao Xue Bao, 30:818–823 (in Chinese).

Liu, M., Zhang, J., 1996. Studies on the mechanisms of immunoregulatory effects of ginsenosides Rg1 in aged rats. Yao Xue Bao, 31:95–100 (in Chinese).

Liu, J., Wang, S., Liu, H., Yang, L., Nan, G., 1995. Stimulatory effect on saponin from Panax ginseng on immune function of lymphocytes in the elderly. Mech. Ageing Dev., 83(1):43–53 (in Chinese). [doi: 10.1016/0047-6374(95)01618-A]

Liu, G., Anderson, C., Scaltreto, H., Barbon, J., Kensil, C.R., 2002. QS-21 structure/function studies: effect of acylation on adjuvant activity. Vaccine, 20(21–22):2808–2815. [doi: 10.1016/S0264-410X(02)00209-8]

Lovgren, K., Lindmark, J., Pipkorn, R., Morein, B., 1987. Antigen presentation of small molecules and synthetic peptides conjugated to a performed ISCOM as carrier. J. Immunol. Meth., 98(1):137–143. [doi: 10.1016/0022-1759(87)90447-9]

Marciani, D.J., Press, J.B., Reynolds, R.C., 2000. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity. Vaccine, 18(27):3141–3151. [doi: 10.1016/S0264-410X(00)00118-3]

Marciani, D.J., Pathak, A.K., Reynolds, R.C., Seitz, L., May, R.D., 2001. Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins. Int. Immunopharmacol., 1(4):813–818. [doi: 10.1016/S1567-5769(01)00016-9]

McElrath, M.J., 1995. Selection of potent immunological adjuvants for vaccine construction. Semin. Cancer Biol., 6(6):375–385. [doi: 10.1016/1044-579X(95)90007-1]

Morein, B., Sundquist, B., Höglund, S., Dalsgaard, K., Osterhaus, A., 1984. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature, 308(5958):457–460. [doi: 10.1038/308457a0]

Mowat, A.M., Donachie, A.M., Reid, G., Jarrett, O., 1991. Immune-stimulating complexes containing Quil A and protein antigen prime Class I MHC-restricted T lymphocytes in-vivo and are immunogenic by the oral route. Immunology, 72(3):317–322.

Mowat, A.M., Smith, R.E., Donachie, A.M., Furrie, E., Grdic, D., Lycke, N., 1999. Oral vaccination with immune stimulating complexes. Immunol. Lett., 65(1–2):133–140. [doi: 10.1016/S0165-2478(98)00136-9]

Oda, K., Matsuda, H., Murakami, T., Katayama, S., Ohgitani, T., Yoshikawa, M., 2000. Adjuvant and haemolytic activities of 47 saponins derived from medicinal and food plants. Biol. Chem., 381(1):67–74. [doi: 10.1515/BC.2000.009]

Oda, K., Matsuda, H., Murakami, T., Katayama, S., Ohgitani, T., Yoshikawa, M., 2003. Relationship between adjuvant activity and amphipathic structure of soyasaponins. Vaccine, 21(17–18):2145–2151. [doi: 10.1016/S0264-410X(02)00739-9]

Plohmann, B., Bader, G., Hiller, K., Franz, G., 1997. Immunomodulatory and antitumoral effects of triterpenoid saponins. Pharmazie, 52(12):953–957.

Riguera, R., 1997. Isolating bioactive compounds from marine organisms. J. Marine Biotechnol., 5:187–193.

Rivera, E., Ekholm, P.F., Inganas, M., Paulie, S., Gronvik, K.O., 2005. The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine, 23(46–47):5411–5419. [doi: 10.1016/j.vaccine.2005.04.007]

Ronnberg, B., Fekadu, M., Behboudi, S., Kenne, L., Morein, B., 1997. Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterolbinding capacity and toxicity. Vaccine, 15(17–18):1820–1826. [doi:10.1016/S0264-410X(97)00139-4]

Sanders, M.T., Brown, L.E., Deliyannis, G., Pearse, M.J., 2005. ISCOM-based vaccines: the second decade. Immunol. Cell Biol., 83(2):119–128. [doi:10.1111/j.1440-1711.2005.01319.x]

Sasaki, S., Sumino, K., Hamajima, K., Fukushima, J., Ishii, N., Kawamoto, S., Mohri, H., Kensil, C.R., Okuda, K., 1998. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J. Virol., 72(6):4931–4939.

Scaglione, F., Ferrara, F., Dugnani, S., Falchi, M., Santoro, G., Fraschini, F., 1990. Immunomodulatory effects of two extracts of Panax ginseng C.A. Meyer. Drugs Exp. Clin. Res., 16(10):537–542.

Singh, M., O’Hagan, D.T., 2003. Invited review recent advances in veterinary vaccine adjuvants. Int. J. Parasitol., 33(5–6):469–478. [doi:10.1016/S0020-7519(03)00053-5]

Sjölander, A., Drane, D., Maraskovsky, E., Scheerlinck, J., Suhrbier, A., Tennent, J., Pearse, M., 2001. Immune responses to ISCOM formulations in animal and primate models. Vaccine, 19(17–19):2661–2665. [doi:10.1016/S0264-410X(00)00497-7]

Smolina, T.P., Solov’eva, T.F., Besednova, N.N., 2001. Immunotropic activity of panaxans-bioglycans isolated from ginseng. Antibiot. Khimioter., 46(7):19–22 (in Russian).

So, H.S., Yoon, H.S., Kwoon, Y.S., Sung, J.H., Lee, T.G., Park, E.N., Cho, H.S., Lee, B.M., Cho, J.M., Ryu, W.S., 1997. Effect of a novel saponin adjuvant derived from Quillaja saponaria on immune response to recombinant hepatitis B surface antigen. Mol. Cells, 7(2):178–186.

Steven, F., Yue, C., 1992. Herbal Emissaries: Bringing Chinese Herbs to the West: A Guide to Gardening, Herbal Wisdom, and Well-Being. Healing Arts Press, Rochester, VT, p.61.

Sun, H.X., 2006. Adjuvant effect of Achyranthes bidentata saponins on specific antibody and cellular response to ovalbumin in mice. Vaccine, 24(17):3432–3439. [doi:10.1016/j.vaccine.2006.02.014]

Sun, H., Yang, Z., Ye, Y., 2006a. Structure and biological activity of protopanaxatriol-type saponins from the roots of Panax notoginseng. Int. Immunopharmacol., 6(1):14–25. [doi:10.1016/j.intimp.2005.07.003]

Sun, K., Wang, C.S., Guo, J., Liu, Y.Y., Wang, F., Liu, L.Y., He, J.G., Fan, J.Y., Han, J.Y., 2006b. Effect of Panax notoginseng saponins on lipopolysaccharide-induced adhesion of leukocytes in rat mesenteric venules. Clin. Hemorheol. Microcirc., 34(1–2):103–108.

Takahashi, H., Takeshita, T., Morein, B., Putney, S., Germain, R.N., Berzofsky, J.A., 1990. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature, 344(6269):873–875. [doi:10.1038/344873a0]

Vogel, F.R., 1995. Immunologic adjuvants for modern vaccine formulations. Ann. N.Y. Acad. Sci., 754 (1 combined vacc):153–160. [doi:10.1111/j.1749-6632.1995.tb44448.x]

Vogel, F.R., 1998. Adjuvants in Perspective. In: Brown, F., Haaheim, L.R. (Eds.), Modulation of the Immune Response to Vaccine Antigens, Vol. 92. Development in Biological Standardization, Basel, Karger, p.241–248.

Vogel, F.R., Powell, M.F., 1995. A Compendium of Vaccine Adyuvantes and Excipients. In: Powell, M.F., Neuman, M.J. (Eds.), Vaccine Design, the Subunit and Adyuvant Approach. Plenum Press, New York, p.141–228.

Wang, X.J., Zhu, L.Z., 1996. Studies on the saponin constituents of Niuxi (Achyrathes Bidentata). J. Fourth Mil. Med. Univ., 17(6):427–430.

Wang, M.Z., Gao, F.Y., Zhang, G.D., Zhang, S.R., 1979. Analysis of ginseng. Acta Pharm. Sin., 14(5):309–315 (in Chinese).

Wang, Y., Qian, X.J., Hadley, H.R., Lau, B.H., 1992. Phytochemicals potentiate interleukin-2 generated lymphokine-activated killer cell cytotoxicity against murine renal cell carcinoma. Mol. Biother., 4(3):143–146.

Wang, M., Guilbert, L.J., Ling, L., Li, J., Wu, Y., Xu, S., Pang, P., Shan, J.J., 2001. Immunomodulating activity of CTV-E002, a proprietary extract from North American ginseng (Panax equinquefolium). J. Pharm. Pharmacol., 53(11):1515–1523. [doi:10.1211/0022357011777882]

Warren, H.S., Chedid, L.A., 1988. Future prospects for vaccine adjuvants. Crit. Rev. Immunol., 8(2):83–101.

Wu, S., Hua, Z.J., Xio, Y.L., Wang, Y., 1991. Effect of Ginsengopolypeptide on the 3H-TdR integration of human blood lymphocyte. Chin. Med. J., 104(5):399–401.

Yang, G.Z., Bao, T., Fu, N., Gen, P.L., 1983. A preliminary study on the immunomodulatory effects of ginseng saponins in vitro and in vivo. J. Norman. Bethune Univ. Med. Sci., 9:1–7.

Yang, Z.G., Sun, H.X., Fang, W.H., 2005. Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice. Vaccine, 23(44):5196–5203. [doi:10.1016/j.vaccine.2005.06.016]

Yesilada, E., Bedir, E., Calis, I., Takaishi, Y., Ohmoto, Y., 2005. Effects of triterpene saponins from Astragalus species on in vitro cytokine release. J. Ethnopharmacol., 96(1–2): 71–77. [doi:10.1016/j.jep.2004.08.036]

Yoshida, Y., Wang, M.Q., Shan, B.E., Yamashita, U., 1997. Immunomodulating activity of Chinese medical herbs and Oldenlandia diffusa in particular. Int. J. Immunopharmacol., 19(7):359–370. [doi:10.1016/S0192-0561(97)00076-3]

Yoshiki, Y., Kudou, S., Okubo, K., 1998. Relationship between chemical structures and biological activities of triterpenoid saponins from soybean (review). Biosci. Biotechnol. Biochem., 62(12):2291–2299. [doi:10.1271/bbb.62.2291]

Yui, S., Ubukata, K., Hodono, K., Kitahara, M., Mimaki, Y., Kuroda, M., Sashida, Y., Yamazaki, M., 2001. Macrophage-oriented cytotoxic activity of novel triterpene saponins extracted from roots of Securidaca inappendiculata. Int. Immunopharmacol., 1(11):1989–2000. [doi:10.1016/S1567-5769(01)00126-6]